Seroatlas · Human Serome Atlas

IDNK

Probable gluconokinase

Also known as: bA522I20.2, C9orf103, GNTK_HUMAN, hGntK

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q5T6J7
Gene
IDNK
Ensembl
ENSG00000148057
Chromosome
9
Canonical length
187 aa
Protein class
Enzymes, Predicted intracellular proteins
Subcellular location
Mitochondria,Cytosol

OverviewNCBI Gene

Predicted to enable gluconokinase activity. Predicted to be involved in carbohydrate metabolic process. [provided by Alliance of Genome Resources, Jul 2025]

Canonical amino-acid sequenceUniProt

187 residues, UniProt reviewed canonical sequence.

>Q5T6J7|IDNK
     1  MAAPGALLVM GVSGSGKSTV GALLASELGW KFYDADDYHP EENRRKMGKG IPLNDQDRIP
    61  WLCNLHDILL RDVASGQRVV LACSALKKTY RDILTQGKDG VALKCEESGK EAKQAEMQLL
   121  VVHLSGSFEV ISGRLLKREG HFMPPELLQS QFETLEPPAA PENFIQISVD KNVSEIIATI
   181  METLKMK

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against IDNK can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Unknown
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.3
Highest tissue expression
66 nTPM

Expression across tissuesHPA

Tissue

  • liver: 66 nTPM
  • basal ganglia: 55 nTPM
  • kidney: 47 nTPM
  • choroid plexus: 38 nTPM
  • thymus: 36 nTPM
  • cerebral cortex: 29 nTPM

Single-cell type

  • enterocytes: 99 nCPM
  • hepatocytes: 64 nCPM
  • epicardial cells: 52 nCPM
  • fallopian tube ciliated cells: 47 nCPM
  • ependymal cells: 46 nCPM
  • mast cells: 43 nCPM

Immune cell

  • basophil: 101 nTPM
  • T-reg: 52 nTPM
  • non-classical monocyte: 48 nTPM
  • memory B-cell: 40 nTPM
  • NK-cell: 33 nTPM
  • gdT-cell: 31 nTPM

Brain region

  • basal ganglia: 24 nTPM
  • hypothalamus: 21 nTPM
  • choroid plexus: 21 nTPM
  • midbrain: 16 nTPM
  • white matter: 16 nTPM
  • cerebral cortex: 16 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.68
gnomAD pLI
0.39
gnomAD missense Z
0.37
DepMap mean gene effect
0
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads IDNK as an antibody target. Whether an autoantibody or antibody against IDNK could matter depends on whether native IDNK is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

IDNK is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label IDNK as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/IDNK. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...